Athenex |
Date/Time | / |
Chg. / Chg.(%) | - / |
Bid | - |
Ask | - |
Open | - |
Previous Close | - |
High | - |
Low | - |
Volume [USD] | - |
Volume [Units] | |
Price fixings | |
ISIN | US04685N1037 |
Security | ATNX |
Exchange | IEX |
Type | Stock |
Other Exchanges
Exchange | Last | Volume | |
---|---|---|---|
Lang & Schwa.. | 0.419 | ![]() |
|
NASDAQ | 0.4330 | ![]() |
494,961 |
Cboe US | 0.43 | ![]() |
13,625 |
IEX | 0.44 | ![]() |
13,590 |
Frankfurt | 0.3493 | ![]() |
0 |
Stuttgart | 0.406 | ![]() |
0 |
München | 0.397 | ![]() |
0 |
Berlin | 0.411 | ![]() |
0 |
Düsseldorf | 0.395 | ![]() |
0 |
gettex | 0.3974 | ![]() |
|
Quotrix | 0.3877 | ![]() |
|
TradeGate | 0.45 | 1,300 |
News
- Athenex Provides Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
03/16/2022 / 21:10 - GlobeNewswire - Athenex to Provide Corporate and Financial Update for the Fourth Quarter and Full Year 2021, on March 15, 2022
03/07/2022 / 14:00 - GlobeNewswire - Athenex Announces Appointment of Chief Financial Officer
02/22/2022 / 14:00 - GlobeNewswire - Athenex to Present at the 11th Annual SVB Leerink Global Healthcare Conference
02/09/2022 / 14:00 - GlobeNewswire - Athenex Announces UK MHRA Validation of the Marketing Authorization Application for Oral Paclitaxel and Encequidar for Review
11/29/2021 / 14:00 - GlobeNewswire